[ad_1]
SAN DIEGO, April 20, 2022 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) securities between May 7, 2021 and February 25, 2022 inclusive (the “Class Period”) have until June 14, 2022 to seek appointment as lead plaintiff in Ortmann v. Aurinia Pharmaceuticals Inc.No. 22-cv-02185 (EDNY). Commenced on April 15, 2022, the Aurinia class action lawsuit charges Aurinia and certain of its top executive officers with violations of the Securities Exchange Act of 1934.
If you suffered significant losses and wish to serve as lead plaintiff of the Aurinia class action lawsuit, please provide your information by clicking here. You can also contact attorney JC Sanchez of Robbins Geller by calling 800/449-4900 or via e-mail at jsanchez@rgrdlaw.com. Lead plaintiff motions for the Aurinia class action lawsuit must be filed with the court no later than June 14, 2022.
CASE ALLEGATIONS: Aurinia is a biopharmaceutical company that develops and commercializes therapies to treat various diseases with unmet medical need in Japan and …
Full story available on Benzinga.com
[ad_2]
Source link
